Kennedy Lewis Capital Co Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Assets and Liabilities

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023
Assets
Investments at fair value
Non-controlled/Non-affiliated Investments
Non-controlled/affiliated
Controlled/affiliated Investments
Total investments at fair value
Cash and cash equivalents
Restricted cash
Restricted cash and cash equivalents
Interest and fee receivable
Non-controlled/Non-affiliated Investments
Controlled/affiliated Investments
Total interest and fee receivable
Deferred financing costs (net of $2,411,821 and $2,009,531 in accumulated amortization at June 30, 2026 and December 31, 2025, respectively)
Deferred offering costs (net of $3,087,919 and $2,938,217 in accumulated amortization at June 30, 2026 and December 31, 2025, respectively)
Subscription receivable
Receivable for investments sold
Derivative assets at fair value (Note 5)
Due from Advisor
Other assets
Total assets

Liabilities
Secured Credit Facility (Note 6)
Deferred financing cost payable
Subscriptions received in advance
Distribution Payable
Payable for investments purchased
Interest and credit facility fee payable
Income incentive fee payable
Management fees payable
Administrative service expense payable
Deferred financing costs payable
Accrued capital gains incentive fee
Interest and credit facility fees payable
Derivative liabilities at fair value (Note 5)
Due to Advisor and affiliates
Offering costs payable
Accrued expenses and other liabilities
Total liabilities

Net Assets
Common shares, $0.01 par value (37,591,410 and 35,262,120 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively)
Additional paid in capital
Distributable earnings (loss)
Class I Shares
Class D Shares
Class S Shares
Total net assets
Common Shares Outstanding
Class I Shares
Class D Shares
Class S Shares
Total common Shares Outstanding
Net Asset value per share
Class I Shares
Class D Shares
Class S Shares
Total net Asset value per share
Total liabilities and net assets

Comments